Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]

Thumbnail
QRCode
Share this
Bevacizumab as a treatment option in gastrointestinal bleeding associated to hereditary hemorrhagic telangiectasia. Case Report [Bevacizumab como opción terapéutica en sangrado gastrointestinal asociado a telangiectasia hemorrágica hereditaria. Reporte de caso]
Date
2019
Author
Bibliographic managers
Metadata
Show full item record
Source
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073739486&doi=10.15446%2frevfacmed.v67n3.68417&partnerID=40&md5=7c45a39e018fe8d40526746065db9a08
URI
http://hdl.handle.net/20.500.12622/3143
DOI
https://doi.org/10.15446/revfacmed.v67n3.68417
Statistics Google Analytics
Collections